Logo image of CPT

CAMDEN PROPERTY TRUST (CPT) Stock Fundamental Analysis

USA - NYSE:CPT - US1331311027 - REIT

101.85 USD
+0.15 (+0.15%)
Last: 10/16/2025, 8:04:00 PM
101.85 USD
0 (0%)
After Hours: 10/16/2025, 8:04:00 PM
Fundamental Rating

4

CPT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 20 industry peers in the Residential REITs industry. There are concerns on the financial health of CPT while its profitability can be described as average. While showing a medium growth rate, CPT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CPT had positive earnings in the past year.
CPT had a positive operating cash flow in the past year.
CPT had positive earnings in each of the past 5 years.
Each year in the past 5 years CPT had a positive operating cash flow.
CPT Yearly Net Income VS EBIT VS OCF VS FCFCPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.71%, CPT is in line with its industry, outperforming 60.00% of the companies in the same industry.
CPT's Return On Equity of 3.39% is in line compared to the rest of the industry. CPT outperforms 55.00% of its industry peers.
With a Return On Invested Capital value of 2.66%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CPT is in line with the industry average of 2.59%.
Industry RankSector Rank
ROA 1.71%
ROE 3.39%
ROIC 2.66%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
CPT Yearly ROA, ROE, ROICCPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

CPT has a Profit Margin of 9.97%. This is comparable to the rest of the industry: CPT outperforms 60.00% of its industry peers.
In the last couple of years the Profit Margin of CPT has declined.
With a Operating Margin value of 18.78%, CPT perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPT has declined.
The Gross Margin of CPT (61.19%) is better than 75.00% of its industry peers.
In the last couple of years the Gross Margin of CPT has remained more or less at the same level.
Industry RankSector Rank
OM 18.78%
PM (TTM) 9.97%
GM 61.19%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
CPT Yearly Profit, Operating, Gross MarginsCPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CPT is destroying value.
Compared to 1 year ago, CPT has less shares outstanding
CPT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CPT has an improved debt to assets ratio.
CPT Yearly Shares OutstandingCPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CPT Yearly Total Debt VS Total AssetsCPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.51, we must say that CPT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CPT (1.51) is better than 75.00% of its industry peers.
The Debt to FCF ratio of CPT is 9.23, which is on the high side as it means it would take CPT, 9.23 years of fcf income to pay off all of its debts.
CPT has a better Debt to FCF ratio (9.23) than 95.00% of its industry peers.
CPT has a Debt/Equity ratio of 0.83. This is a neutral value indicating CPT is somewhat dependend on debt financing.
CPT has a Debt to Equity ratio of 0.83. This is in the better half of the industry: CPT outperforms 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 9.23
Altman-Z 1.51
ROIC/WACC0.37
WACC7.24%
CPT Yearly LT Debt VS Equity VS FCFCPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

CPT has a Current Ratio of 0.10. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.10, CPT is doing worse than 80.00% of the companies in the same industry.
CPT has a Quick Ratio of 0.10. This is a bad value and indicates that CPT is not financially healthy enough and could expect problems in meeting its short term obligations.
CPT has a worse Quick ratio (0.10) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
CPT Yearly Current Assets VS Current LiabilitesCPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

CPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -62.09%.
CPT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.43% yearly.
The Revenue has been growing slightly by 0.77% in the past year.
The Revenue has been growing by 8.46% on average over the past years. This is quite good.
EPS 1Y (TTM)-62.09%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%-22.5%
Revenue 1Y (TTM)0.77%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.42%

3.2 Future

Based on estimates for the next years, CPT will show a small growth in Earnings Per Share. The EPS will grow by 1.21% on average per year.
Based on estimates for the next years, CPT will show a small growth in Revenue. The Revenue will grow by 4.51% on average per year.
EPS Next Y-18.57%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year2.44%
Revenue Next 2Y2.53%
Revenue Next 3Y3.29%
Revenue Next 5Y4.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPT Yearly Revenue VS EstimatesCPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
CPT Yearly EPS VS EstimatesCPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 73.80 indicates a quite expensive valuation of CPT.
CPT's Price/Earnings ratio is in line with the industry average.
CPT is valuated expensively when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 68.78 indicates a quite expensive valuation of CPT.
The rest of the industry has a similar Price/Forward Earnings ratio as CPT.
CPT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 73.8
Fwd PE 68.78
CPT Price Earnings VS Forward Price EarningsCPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CPT is valued a bit cheaper than 80.00% of the companies in the same industry.
85.00% of the companies in the same industry are more expensive than CPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.27
EV/EBITDA 16.57
CPT Per share dataCPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)171.22
EPS Next 2Y-11.25%
EPS Next 3Y1.21%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.12%, CPT is a good candidate for dividend investing.
CPT's Dividend Yield is slightly below the industry average, which is at 6.43.
CPT's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

The dividend of CPT has a limited annual growth rate of 4.99%.
CPT has been paying a dividend for at least 10 years, so it has a reliable track record.
CPT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.99%
Div Incr Years7
Div Non Decr Years14
CPT Yearly Dividends per shareCPT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

293.28% of the earnings are spent on dividend by CPT. This is not a sustainable payout ratio.
CPT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP293.28%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
CPT Yearly Income VS Free CF VS DividendCPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CPT Dividend Payout.CPT Dividend Payout, showing the Payout Ratio.CPT Dividend Payout.PayoutRetained Earnings

CAMDEN PROPERTY TRUST

NYSE:CPT (10/16/2025, 8:04:00 PM)

After market: 101.85 0 (0%)

101.85

+0.15 (+0.15%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-23 2025-10-23/amc
Inst Owners96.78%
Inst Owner Change-0.03%
Ins Owners1.25%
Ins Owner Change-0.27%
Market Cap10.88B
Analysts73.1
Price Target124.38 (22.12%)
Short Float %2.76%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend4.15
Dividend Growth(5Y)4.99%
DP293.28%
Div Incr Years7
Div Non Decr Years14
Ex-Date09-30 2025-09-30 (1.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.57%
Min EPS beat(2)-0.59%
Max EPS beat(2)5.72%
EPS beat(4)1
Avg EPS beat(4)-4.05%
Min EPS beat(4)-12.31%
Max EPS beat(4)5.72%
EPS beat(8)4
Avg EPS beat(8)60.9%
EPS beat(12)7
Avg EPS beat(12)54.23%
EPS beat(16)8
Avg EPS beat(16)82.47%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.57%
Max Revenue beat(2)-0.45%
Revenue beat(4)0
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-1.54%
Max Revenue beat(4)-0.45%
Revenue beat(8)0
Avg Revenue beat(8)-0.95%
Revenue beat(12)0
Avg Revenue beat(12)-0.89%
Revenue beat(16)3
Avg Revenue beat(16)5.31%
PT rev (1m)-1.08%
PT rev (3m)-6.06%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.37%
EPS NY rev (1m)21.5%
EPS NY rev (3m)17.73%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 73.8
Fwd PE 68.78
P/S 6.97
P/FCF 26.27
P/OCF 13.73
P/B 2.37
P/tB 2.37
EV/EBITDA 16.57
EPS(TTM)1.38
EY1.35%
EPS(NY)1.48
Fwd EY1.45%
FCF(TTM)3.88
FCFY3.81%
OCF(TTM)7.42
OCFY7.28%
SpS14.61
BVpS42.93
TBVpS42.93
PEG (NY)N/A
PEG (5Y)171.22
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 3.39%
ROCE 3.37%
ROIC 2.66%
ROICexc 2.67%
ROICexgc 2.75%
OM 18.78%
PM (TTM) 9.97%
GM 61.19%
FCFM 26.55%
ROA(3y)4.38%
ROA(5y)3.73%
ROE(3y)8.22%
ROE(5y)7.1%
ROIC(3y)2.74%
ROIC(5y)2.62%
ROICexc(3y)2.77%
ROICexc(5y)2.72%
ROICexgc(3y)2.85%
ROICexgc(5y)2.8%
ROCE(3y)3.46%
ROCE(5y)3.32%
ROICexcg growth 3Y0.86%
ROICexcg growth 5Y-2.21%
ROICexc growth 3Y1.1%
ROICexc growth 5Y-2.02%
OM growth 3Y-0.89%
OM growth 5Y-4.58%
PM growth 3Y-26.44%
PM growth 5Y-13.1%
GM growth 3Y0.19%
GM growth 5Y-0.06%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 9.23
Debt/EBITDA 4.32
Cap/Depr 63.86%
Cap/Sales 24.25%
Interest Coverage 2.12
Cash Conversion 89.5%
Profit Quality 266.19%
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z 1.51
F-Score4
WACC7.24%
ROIC/WACC0.37
Cap/Depr(3y)72.34%
Cap/Depr(5y)87.06%
Cap/Sales(3y)27.91%
Cap/Sales(5y)32.43%
Profit Quality(3y)124.82%
Profit Quality(5y)99.59%
High Growth Momentum
Growth
EPS 1Y (TTM)-62.09%
EPS 3Y13.97%
EPS 5Y0.43%
EPS Q2Q%-22.5%
EPS Next Y-18.57%
EPS Next 2Y-11.25%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)0.77%
Revenue growth 3Y10.52%
Revenue growth 5Y8.46%
Sales Q2Q%2.42%
Revenue Next Year2.44%
Revenue Next 2Y2.53%
Revenue Next 3Y3.29%
Revenue Next 5Y4.51%
EBIT growth 1Y-7.46%
EBIT growth 3Y9.54%
EBIT growth 5Y3.5%
EBIT Next Year207.48%
EBIT Next 3Y49.06%
EBIT Next 5Y37.61%
FCF growth 1Y7.34%
FCF growth 3Y36.84%
FCF growth 5Y20.83%
OCF growth 1Y1.55%
OCF growth 3Y10.3%
OCF growth 5Y6.88%